Dr Mathew Samuel
Esketamine: a new frontier in treatment-resistant depression
Esketamine nasal spray has emerged as a novel third-line treatment for adults with treatment-resistant depression.
About the Author
Dr Mathew Samuel
Subscribe to continue reading
Log in or create an account to access the full article.